Clinical Trial Update: Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer

View source ↗

Summary

A clinical trial evaluating sequential transarterial chemoembolization (TACE) and stereotactic body radiotherapy (SBRT) in combination with targeted immunothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: HCC - Hepatocellular Carcinoma, SBRT | Status: ACTIVE_NOT_RECRUITING